Successful Development of the World’s First Compact and Robust High-Precision Optical Lattice Clock with a 250-liter Volume — Toward Real-World Applications of Optical Lattice Clocks —

As part of the JST-Mirai Program, researchers from The University of Tokyo and RIKEN, in collaboration with Shimadzu Corporation and JEOL Limited, have successfully developed a compact and robust high-precision optical lattice clock. Optical lattice clocks, which utilize the optical transition of atoms confined in standing waves of light, offer a timekeeping uncertainty that is [...]

XRF Acquires Labfit

XRF Scientific Ltd (“XRF” or “The Company”) is pleased to advise that it has entered into a binding but conditional Share Purchase Agreement ("Agreement") to acquire 100% of the shares in Labfit Pty Ltd ("Labfit"). The Agreement is conditional on the satisfaction or waiver by 13 February 2025 (or such other date which is agreed) [...]

BICO has entered into an agreement to divest Nanoscribe

BICO has entered into an agreement to divest Nanoscribe to LAB14 GmbH to an equity value of EUR 26m (SEK 294m). The transaction is expected to close during the fourth quarter 2024. The rationale behind the divestment is in line with the updated strategy, BICO 2.0, where Nanoscribe has been concluded non-core due to its [...]

Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA

New research labs and process development services to enable next generation therapeutics Up- and downstream process optimization, proof of concept runs, demos and trainings for customers Coming 2025: two GMP suites for implementing novel manufacturing processes Aubagne, France -- Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for [...]

Quanterix Announces Receipt of Expected Notice from Nasdaq

BILLERICA, Mass. -- Quanterix Corporation (NASDAQ: QTRX) today announced that it received a notice (the "Notice") on November 21, 2024 from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Form 10-Q"), it is no [...]

Standard BioTools Expands SomaScan Offering with Advanced Antibody Profiling

The KREX™ offering provides additional high plex proteomic solutions for biopharma and  translational research end markets SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (Nasdaq: LAB) ("Standard BioTools" or the "Company") today announced the addition of KREX™ precision antibody profiling services and kits to its SomaScan™ suite of solutions.  The expanded offering enables the detection of [...]

Rigaku BioScience Lab Opens in USA

- To provide new visualization technologies for biopharmaceuticals at the world's largest bio-science research hub - TOKYO -- Rigaku Corporation, a Rigaku Holdings Group company that serves as a global solution partner for X-ray analytical equipment (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; "Rigaku"), opened Rigaku BioScience Lab in Cambridge, Massachusetts, USA. Rigaku has begun operation [...]

Parse Biosciences Partners with OMAPiX to Expand Access to Single Cell Sequencing

Omapix joins a growing network of certified service providers delivering Parse Biosciences’ innovative technology SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that OMAPiX has been certified as the latest member of its Certified Service Provider (CSP) Program. With this partnership, OMAPiX joins a distinguished network of [...]

PAC Releases the New ZyNthAir Gas Mixer as a Reliable Alternative to Synthetic Air

HOUSTON, TEXAS -- PAC, a global leader in advanced analytical instruments for laboratories and online process applications, is pleased to announce the release of its latest software solution, RGA/NGA XLNC for the IRIS platform. This now integrated solution replaces the former GasXLNC stand-alone software, providing an upgraded, comprehensive tool for gas chromatograph (GC) analysis and [...]

Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event

Provides Update on the Company’s Innovation Roadmap & New Development Partnerships Highlights new Distribution Agreement with Avantor in the U.S. and Canada BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event that was hosted in New York City on November 20th, [...]

Access IBO on Knowledge Center